JOINT VENTURE FOR DEVELOPMENT OF APO E MIMETIC PEPTIDE MOLECULE AEM-28 AND ANALOGS - Additional Information (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 83 Months Ended
Aug. 11, 2017
Jul. 14, 2017
Aug. 03, 2012
Oct. 27, 2017
Aug. 31, 2017
Aug. 25, 2016
Mar. 31, 2016
Mar. 31, 2019
Mar. 31, 2018
Jun. 30, 2019
Dec. 31, 2018
Jun. 30, 2019
Related Party Transaction [Line Items]                        
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     $ 6,000,000             $ 6,000,000   $ 6,000,000
Joint Venture Investments In Voting Common Ownership Units (in shares)     600,000                  
Joint Venture Investments In Non Voting Preferred Ownership Units     5,000,000                  
Joint Venture, Operating Expenses, Inter Company Transactions                   1,191,000   10,789,000
Joint Venture, Operating Expenses Allocated To Company                       9,177,000
Percentage Of Non Royalty Income 5.00%   5.00%                  
Conversion of Stock, Shares Converted (3,500,000)                      
Conversion of Stock, Shares Issued             120,000          
Joint Venture Method Investment Ownership Percentage     60.00%                  
Proceeds from Issuance of Preferred Stock and Preference Stock                   0    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           33,088            
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 10.70            
Management Fees               $ 50,000        
Operating Expenses Net Of Elimination Of Intercompany Transactions                   1,191,000    
Conversion of Stock, Amount Converted $ 3,500,000                      
Conversion of Stock, Amount Issued $ 1,000,000                      
Interest Payable                   $ 287,000 $ 213,000 $ 287,000
Accrued Professional Fees         $ 20,000              
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant                     83,480  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross       14,126                
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price       $ 10.70                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage                     50.00%  
Ownership As Converted [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage                     65.11%  
Ownership As Converted Including Options And Warrants [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage       64.31%                
Joint Venture [Member]                        
Related Party Transaction [Line Items]                        
Noncontrolling Interest, Ownership Percentage by Parent                   100.00%   100.00%
Series B1 Preferred Stock [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000            
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           1,012,000            
Proceeds from Issuance of Preferred Stock and Preference Stock           946,000            
Payments of Stock Issuance Costs           $ 66,000            
Stock Issued During Period, Shares, New Issues           94,537            
Management Fees         $ 300,000              
Management Fee Expense                 $ 150,000 $ 150,000    
Accrued Professional Fees                   460,000   $ 460,000
Series B2 Preferred Stock [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Losses Recognition Criteria, Common Ownership Equity           $ 946,000            
Proceeds From Issuance Of Preferred Stock Before Adjusted Stock Issuance Costs           $ 1,012,000            
Proceeds from Issuance of Preferred Stock and Preference Stock                   946,000    
Payments of Stock Issuance Costs   $ 287,000                    
Stock Issued During Period, Shares, Acquisitions 93,458       93,458 93,458            
Stock Issued During Period, Value, Acquisitions $ 1,000,000       $ 1,000,000 $ 1,000,000            
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs $ 15,000                      
Series B1 And B2 Preferred Stock [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage     62.20%                  
Series A Preferred Stock [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage     69.75%                  
Revolving Credit Facility [Member]                        
Related Party Transaction [Line Items]                        
Long-term Line of Credit                   1,760,000   1,760,000
Interest Payable                   160,000   160,000
Preferred Stock [Member]                        
Related Party Transaction [Line Items]                        
Conversion of Stock, Shares Converted             1,500,000          
Noncontrolling Interest [Member]                        
Related Party Transaction [Line Items]                        
Noncash or Part Noncash Acquisition, Other Liabilities Assumed                       $ 667,000
Maximum [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage             64.00%          
Minimum [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Method Investment Ownership Percentage             60.00%          
Exclusive License Agreement [Member]                        
Related Party Transaction [Line Items]                        
Percentage Of Royalty Payment           3.00%            
Annual Maintenance Payments           $ 25,000            
Exclusive License Agreement [Member] | Maximum [Member]                        
Related Party Transaction [Line Items]                        
Milestone Payments           500,000            
Royalty Expense     $ 1,000,000                  
Exclusive License Agreement [Member] | Minimum [Member]                        
Related Party Transaction [Line Items]                        
Milestone Payments           $ 50,000            
Royalty Expense     $ 500,000                  
Lipimetix [Member]                        
Related Party Transaction [Line Items]                        
Joint Venture Investments Common Ownership Units, Co-venture (in shares)     400,000                  
Ownership Percentage Co-venture     40.00%                  
Noncash or Part Noncash Acquisition, Other Liabilities Assumed                   667,000    
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)     $ 378,000             $ 378,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross                     81,479  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                     $ 1.07  
Voting Common Ownership Units [Member]                        
Related Party Transaction [Line Items]                        
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     1,000,000                  
Non Voting Preferred Ownership Units [Member]                        
Related Party Transaction [Line Items]                        
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures     $ 5,000,000